Expertise in
4
conditions

Alberto Zambelli

ASST Bergamo Ovest, BG, 
Treviglio, IT 
Expertise in
4
conditions
ASST Bergamo Ovest, BG, 
Treviglio, IT 

Overview

Alberto Zambelli practices practicing medicine in Treviglio, Italy.

Mr. Zambelli is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Tissue Biopsy, and Mastectomy.

He is actively involved in clinical research, co-authoring 204 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

ASST Bergamo Ovest, BG, Treviglio, Italy
Other Locations
ASST Papa Giovanni XXIII, BG, Bergamo, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II Trial of Atezolizumab Plus CArboplatin Plus Nab-paclitaxel as First-line Therapy in Metastatic Triple-negative PD-L1 Positive Breast Cancer Patients - the GIM25-CAPT Trial
A Phase II Trial of Atezolizumab Plus CArboplatin Plus Nab-paclitaxel as First-line Therapy in Metastatic Triple-negative PD-L1 Positive Breast Cancer Patients - the GIM25-CAPT Trial
Enrollment Status: Unknown
Publish Date: February 01, 2024
Intervention Type: Combination product
Study Drugs: Atezolizumab, Paclitaxel, Carboplatin
Study Phase: Phase 2
Multicenter, Randomized, Phase II Study of Neoadjuvant Chemotherapy Associated or Not With Zoledronate and Atorvastatin in Triple Negative Breast Cancers - YAPPETIZER Study
Multicenter, Randomized, Phase II Study of Neoadjuvant Chemotherapy Associated or Not With Zoledronate and Atorvastatin in Triple Negative Breast Cancers - YAPPETIZER Study
Enrollment Status: Completed
Publish Date: October 19, 2023
Intervention Type: Drug
Study Drugs: Zoledronate, Atorvastatin, Standard neoadjuvant chemotherapy
Study Phase: Phase 2
Phase II, Open Label, Randomized, Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Subcutaneous (SC) Trastuzumab in Patients With Operable or Locally Advanced/Inflammatory HER2-positive Breast Cancer (ImmunHER)
Phase II, Open Label, Randomized, Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Subcutaneous (SC) Trastuzumab in Patients With Operable or Locally Advanced/Inflammatory HER2-positive Breast Cancer (ImmunHER)
Enrollment Status: Unknown
Publish Date: October 14, 2020
Intervention Type: Biological, Drug
Study Drugs: Trastuzumab, Pertuzumab, Docetaxel
Study Phase: Phase 2
A Multicenter, Single-arm, Phase II Study to Evaluate the Activity of Pre-operative Zoledronate in Triple Negative Breast Cancer Patients, According to p53 Level
A Multicenter, Single-arm, Phase II Study to Evaluate the Activity of Pre-operative Zoledronate in Triple Negative Breast Cancer Patients, According to p53 Level
Enrollment Status: Terminated
Publish Date: November 06, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

204 Total Publications

Switching CDK4/6 inhibitors to overcome toxicity in HR-positive/HER2-negative advanced breast cancer.
Switching CDK4/6 inhibitors to overcome toxicity in HR-positive/HER2-negative advanced breast cancer.
Journal: Tumori
Published: July 31, 2026

Frequently Asked Questions about Alberto Zambelli

Is Alberto Zambelli a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alberto Zambelli is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alberto Zambelli participate in research or clinical trials?

Yes. Alberto Zambelli has published 204 articles and abstracts on conditions like Breast Cancer. You can view a list of Alberto Zambelli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zambelli's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile